Mgr. Tomáš Loja, Ph.D.
Technology expert, Genomics Core Facility
office: bldg. E35/234
Kamenice 753/5
625 00 Brno
| phone: | +420 549 49 7455 |
|---|---|
| e‑mail: |
| social and academic networks: |
|---|
Total number of publications: 116
2016
-
Co-expression of cancer stem cell markers corresponds to a pro-tumorigenic expression profile in pancreatic adenocarcinoma
PLOS One, year: 2016, volume: 11, edition: 7, DOI
-
Impaired mitophagy in Fanconi anemia is dependent on mitochondrial fission
Oncotarget, year: 2016, volume: 7, edition: 36, DOI
2015
-
B cell surface molecules expression changes during in-vitro standard cultivation and thein impact on anti-CD20 antibodies efficacy – room for interlaboratory variability.
Year: 2015, type: Conference abstract
2014
-
Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8-color flow cytometry protocol in routine hematological practice.
International Journal of Laboratory Hematology, year: 2014, volume: 36, edition: 2, DOI
-
Distinct in vitro sensitivity of p53-mutated and ATM-mutated chronic lymphocytic leukemia cells to ofatumumab and rituximab
Experimental Hematology, year: 2014, volume: 42, edition: 10, DOI
-
Gentické aberace v B-lymfocytu chronické lymfocytární leukémie - vznik, selekce a dopad na terapii
Year: 2014, type: Requested lectures
-
Influence of pulsed electromagnetic and pulsed vector magnetic potential field on the growth of tumor cells
Electromagnetic Biology and Medicine, year: 2014, volume: 33, edition: 3, DOI
2013
-
Expression of the stem cell marker nestin in leukemia cells
Year: 2013, type: Requested lectures
2012
-
Exprese nestinu i v nádorových buňkách hematologických malignit - leukémií a lymfomů
Year: 2012, type: Conference abstract
-
In vitro testování účinnosti na komplementu záviské cytotoxity monoklonálních protilátek určených pro léčbu B-buněčných malignit
Year: 2012, type: Conference abstract